Strategies for building reference standards for autoantibodies

Frontiers in Immunology

Volumn 6, Issue APR, 2015, Pages

  Sheldon, Joanna ^a   Dellavance, Alessandra ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b Fleury   (Brazil)

Author keywords

Autoantibodies; Autoimmunity testing; Monoclonal antibodies; Quality control; Reference standards

Indexed keywords

ANTIGEN; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; RHEUMATOID FACTOR;

AFFINITY PURIFICATION; ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CLINICAL LABORATORY; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; PLASMAPHERESIS; SERUM; STANDARD; VALIDITY;

EID: 84934274346     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00194     Document Type: Article

References (11)

1. Greg MW, Myers GL, Lou Gantzer M, Kahn SE, Schönbrunner ER, Thienpont LM, et al. Roadmap for harmonisation of clinical laboratory measurement procedures. Clin Chem (2011) 57:1108-17. doi:10.1373/clinchem.2011.164012
2. Whicher JT, Baudne S, Bienvenu J, Blirup-Jensen S, Carlstrom A, Dati F, et al. New initiatives in the standardization of protein measurements. Pure Appl Chem (1996) 68:1851-6. doi:10.1351/pac199668101851
3. Andreoli L, Nalli C, Motta M, Norman GL, Shums Z, Encabo S, et al. Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? Ann Rheum Dis (2011) 70:380-3. doi:10.1136/ard.2010.137281
4. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis (2010) 69:1420-2. doi:10.1136/ard.2009.127100
5. Hawa MI, Fava D, Medici F, Deng YJ, Notkins AL, De Mattia G, et al. Antibodies to IA-2 and GAD65 in type 1 and type 2. Diabetes Care (2000) 23:228-33. doi:10.2337/diacare.23.2.228
6. Eisenberg RA, Dyer K, Craven SY, Fuller CR, Yount WJ. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest (1985) 75:1270-7. doi:10.1172/JCI111826
7. Chan EK, Fritzler MJ, Wiik A, Andrade LE, Reeves WH, Tincani A, et al. The IUIS/WHO/AF/CDC committee for the standardization of autoantibodies in rheumatic and related diseases-AutoAbSC. Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev (2007) 6:577-80. doi:10.1016/j.autrev.2007.05.001
8. Merlini G, Blirup-Jensen S, Johnson AM, Sheldon J, Zegers I, IFCC Committee on Plasma Proteins (C-PP). Standardizing plasma protein measurements worldwide: a challenging enterprise. Clin Chem Lab Med (2010) 48:1567-75. doi:10.1515/CCLM.2010.314
9. Certification Report. The Certification of Anti-Myeloperoxidase Immunoglobulin G in Human Serum ERM®-DA476/IFCC, European Commission. Joint Research Centre, Institute of Reference Materials and Measurements, EUR 26975 EN, Geel (2015).
10. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum (2011) 63:191-200. doi:10.1002/art.30084
11. Mahler M, Parker T, Peebles CL, Andrade LE, Swart A, Carbone Y, et al. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol (2012) 39:2104-10. doi:10.3899/jrheum.120598